Skip to content

2nd Annual Genotoxic Impurities in Pharmaceuticals Virtual Conference 2021

Calendar icon to

Proudly supported by

Speakers

Michael Burns

Principal Research Scientist at Lhasa Limited, UK

Margaret Maziarz

Principal Scientist, Scientific Operations | Waters Corporation, USA

Daniel Roberts

Genetic Toxicologist and Flow Cytometrist | Charles River Laboratories, USA

David Kirkland

Genetox Consultant | Kirkland Consulting, UK

Carol Beevers

Managing Scientist | Exponent International Ltd, UK

Stephen Dertinger

Director of Research | Litron Laboratories, Rochester, USA

Michelle Kenyon

Associate research fellow in Drug Safety | Pfizer Global Research and Development, USA

Denis Polikarpov

Qepler

Mike Urquhart

Scientific Director | GlaxoSmithKline, UK

Rachael Tennant

Senior Research Scientist | Lhasa Limited, UK

Vimal Sachdeva

Technical Officer (Expert Inspector) | World Health Organization (WHO), CH

george johnson

Associate Professor in the Institute of Life Science | Swansea University, UK

Carla Landolfi, ERT

European Registered Toxicologist (ERT) CEO - Toxicology Risk Assessor | ToxHub Srl, IT

Raphy Nudelman

Director, Chemical & Computational Toxicology | Teva Pharmaceutical Industries Ltd., IL

Mark Harrison

Principal Analyst | AstraZeneca, UK

David Lovell

Reader in Medical Statistics | St. George’s University, UK

Abby Myhre

Technical Lead | Corteva, USA

Joerg Freudenberger

Manager Strategy & Global Business Development | Intertek (Schweiz) AG, CH

Tom van Wijk

Principal Scientist, Analytical Science and Technology Team lead Pharmaceutical analysis | Abbott Healthcare Products

Ron Brown

Owner and Principal Toxicologist | Risk Science Consortium, LLC

The event is over

Hosted by

Qepler

Share on